Search

Your search keyword '"Machulda, Mary M"' showing total 1,692 results

Search Constraints

Start Over You searched for: Author "Machulda, Mary M" Remove constraint Author: "Machulda, Mary M"
1,692 results on '"Machulda, Mary M"'

Search Results

7. Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging

10. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

14. Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET

19. P2‐314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

24. Mayo Normative Studies: regression‐based normative data for remote self‐administration of the Stricker Learning Span, Symbols Test and Mayo Test Drive Screening Battery Composite for ages 33‐100 and validation in MCI and dementia.

26. Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging

27. Artificial Intelligence–Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts

28. 1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults

29. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease

33. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition

39. Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers.

40. Non-rapid eye movement sleep slow-wave activity features are associated with amyloid accumulation in older adults with obstructive sleep apnoea.

41. Can integration of Alzheimer's plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction?

46. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease

47. Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease

48. Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease

50. Usability of a Self‐Administered Cognitive Assessment in Patients with Progressive Supranuclear Palsy and Correlation with Traditional Neuropsychological Tests: A Mayo Test Drive Pilot Study.

Catalog

Books, media, physical & digital resources